戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1  of ICU admission, or if a surrogate was readily available, consent was sought prior to initial sample collection; otherw
2  following which 1295 families were approached for consent; consent was provided for MITS by 963 (74%) of 1295 eligible c
3 n; otherwise, a waiver of consent was granted, and deferred consent was sought 3 days later.
4                    For neonates who died of those enrolled, consent was requested from parents for post-mortem examinatio
5  This scoping review of the literature on requesting family consent was prepared to support of the development of leading
6                                                    Informed consent was obtained for MR imaging.
7                                                    Informed consent was obtained from all participants.
8                                                    Informed consent was obtained from all patients.
9                                                    Informed consent was obtained from all subjects.
10                                                    Informed consent was obtained from potential enrollees.
11                                                    Informed consent was obtained from the patient or next-of-kin.
12                                                    Informed consent was provided according to the last will of the donors
13 ondition and the poor prognosis to the patient, an informed consent was obtained after she opted for medical termination
14                                                 An informed consent was obtained after she opted for medical termination
15 study had institutional review board approval, and informed consent was obtained from 72 patients with breast cancer befo
16 study was approved by the ethics review board, and informed consent was obtained.
17 titutional review board approval was obtained, and informed consent was waived in this HIPAA-compliant retrospective stud
18 as approved by the institutional review board, and informed consent was waived.
19 titutional review board approval, and the need for informed consent was waived.
20 titutional review board; the requirement to obtain informed consent was waived.
21 proval was obtained, and the requirement to obtain informed consent was waived.
22 tional review board, and the requirement to obtain informed consent was waived.
23                          The requirement to obtain informed consent was waived.
24 rd approved this retrospective study and waiver of informed consent was obtained.
25 Act-compliant retrospective study, and a waiver of informed consent was received.
26 retrospective, HIPAA-compliant, multicenter study; informed consent was waived.
27                                            Written informed consent was obtained from 67 consecutive patients (57 years +
28                                            Written informed consent was obtained from all participants before enrollment
29 was approved by the local ethics board and written informed consent was obtained from all participants.
30 /- SD, 34.3 +/- 6.5 y) were recruited, and written informed consent was obtained from all participants.
31 approved by the local ethics committee and written informed consent was obtained from all participants.
32 ved by the institutional review board, and written informed consent was obtained from all study participants.
33 proved by the local ethics committees, and written informed consent was obtained from all subjects prior to enrollment.
34 multi-institutional HIPAA-compliant study; written informed consent was obtained from all subjects.
35                                            Written informed consent was obtained from all subjects.
36 pproved by the local ethics committee, and written informed consent was obtained from each patient.
37 pproved by the institutional board review; written informed consent was obtained from healthy subjects and was waived for
38                                            Written informed consent was obtained from patients or their parents.
39                Materials and Methods After written informed consent was obtained, 8869 women (age range, 29-85 years; mea
40 maging datasets were acquired at 3 T after written informed consent was obtained.
41 by age, and interviews occurred only after written informed consent was obtained.
42                                            Written informed consent was provided by all women who entered the trial.
43                                            Written informed consent was waived.
44                                         Institutional-level consent was obtained, and all women presenting for maternity
45 search assistants photographed abnormalities after maternal consent was obtained.
46  prior to initial sample collection; otherwise, a waiver of consent was granted, and deferred consent was sought 3 days l
47 s Institutional review board approval was given and patient consent was not required for this study.
48 data were collected from contemporaneous notes, and patient consent was obtained.
49 an institutional ethics committee, and the need for patient consent was waived.
50 eview board, and the requirement to obtain informed written consent was waived.